These data may explain why IL-17F is also the dominant IL-17 isoform expressed in inflammatory diseases such as psoriasis, psoriatic arthritis and ankylosing spondylitis where IL-17F levels are measured to be at least 30-fold higher than IL-17A (49). This evidence concerns the gene IL17A and psoriatic arthritis.